Literature DB >> 34244973

Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.

Yan Zheng1, Lei Xie1, Shuwen Xu1, Weidong Yan2, Hongzhen Zhang1, Yali Meng1, Jingqiao Liu3, Xujing Wei4.   

Abstract

To explore the mechanism of miR-202-5p targeting the expression of PIK3CA and mediating the activation of PI3K/Akt/mTOR signaling pathway on the proliferation, invasion, and epithelial-mesenchymal transition (EMT) of cervical cancer. The objects of study were 105 cases of cervical cancer and their corresponding normal tissues. qRT-PCR was used to detect the expression of miR-202-5p and PIK3CA in adjacent normal tissue and cervical cancer tissue. Dual luciferase reporter assay was used to verify the targeting relationship between miR-202-5p and PIK3CA gene. Human cervical cancer cell lines HPV-16E6, SiHa, HeLa, and CaSki were purchased for our cell experiments. The expression levels of PIK3CA in the cells were detected by qRT-PCR. The cell line with higher expression levels was selected to complete the follow-up experiment. The cultured cells were transfected and divided into the miR-202-5p mimic NC group, miR-202-5p mimic group, miR-202-5p inhibitor NC group, miR-202-5p inhibitor group, siRNA-PIK3CA NC group, siRNA-PIK3CA group, miR-202-5p inhibitor NC + siRNA-PIK3CA NC group, miR-202-5p inhibitor + siRNA-PIK3CA NC group, and miR-202-5p inhibitor + siRNA-PIK3CA group. QRT-PCR was used to detect the expression of miR-202-5p. Western blot and qRT-PCR were applied to detect the mRNA and protein expression levels of related pathway proteins (PIK3CA, PI3K, PTEN, p-Akt1, and p-mTOR) and epithelial-mesenchymal transition-related factors (N-cadherin, E-cadherin, and vimentin). Cell proliferation was detected by plate colony formation assay. Transwell assay was used to detect the invasion ability of each group. When compared with the adjacent tissues, PIK3CA mRNA expression level was significantly increased and miR-202-5p expression level was significantly decreased in cervical cancer tissues (all P < 0.05). PIK3CA was a target gene of miR-202-5p. The mRNA expression level of PIK3CA in SiHa cervical cancer cells was significantly higher than that in CaSki, HeLa, and HPV-16E6 cells (all P < 0.05), and SiHa cervical cancer cells were selected to complete the follow-up experiments. When compared with the corresponding NC group, the expression of miR-202-5p in miR-202-5p mimic group was increased. In addition, the mRNA and protein expression levels of E-cadherin and PTEN in miR-202-5p mimic and siRNA-PIK3CA groups were increased, and the protein expression of p-Akt1 and p-mTOR was decreased, and also, the mRNA and protein expression levels of PIK3CA, PI3K, N-cadherin, and vimentin were decreased (all P < 0.05); in miR-202-5p inhibitor group, the expression levels of miR-202-5p, E-cadherin, and PTEN decreased, the protein expression of p-Akt1 and p-mTOR increased, and the mRNA and protein expression of PIK3CA, PI3K, N-cadherin, and vimentin increased in miR-202-5p inhibitor group (all P < 0.05); in miR-202-5p inhibitor + siRNA-PIK3CA group, the expression of miR-202-5p decreased (P < 0.05), but the mRNA and protein expression of PIK3CA, PI3K, p-Akt1, p-mTOR, N-cadherin, E-cadherin, and vimentin had no significant changes (all P > 0.05). When compared with the corresponding NC group, the number of cell clones in miR-202-5p mimic group and siRNA-PIK3CA group was decreased, and the invasion ability of miR-202-5p inhibitor group was increased, and the invasion ability was enhanced (all P < 0.05); miR-202-5p inhibitor + siRNA-PIK3CA group showed no significant change in the number of cell clones and the rate of invasion (P > 0.05). In conclusion, the overexpression of miR-202-5p can suppress PIK3CA gene expression and the activation of PI3K/Akt/mTOR signaling pathway to suppress the proliferation, invasion, and EMT of cervical cancer.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cervical cancer; Epithelial–mesenchymal transition; PI3K/Akt/mTOR signaling pathway; PIK3CA gene; miR-202-5p

Mesh:

Substances:

Year:  2021        PMID: 34244973     DOI: 10.1007/s11010-021-04211-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

Review 1.  Cervical cancer: screening, diagnosis and staging.

Authors:  Panagiotis Tsikouras; Stefanos Zervoudis; Bachar Manav; Eirini Tomara; George Iatrakis; Constantinos Romanidis; Anastasia Bothou; George Galazios
Journal:  J BUON       Date:  2016 Mar-Apr       Impact factor: 2.533

Review 2.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

3.  Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women's Hospital in China: Analysis of 1,248,785 Pap Test Reports.

Authors:  Xiang Tao; R Marshall Austin; Hao Zhang; Lihong Zhang; Jianan Xiao; Li Wang; Xianrong Zhou; Chengquan Zhao
Journal:  Acta Cytol       Date:  2016-01-21       Impact factor: 2.319

4.  Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis.

Authors:  Li Gao; Li-Jie Zhang; Sheng-Hua Li; Li-Li Wei; Bin Luo; Rong-Quan He; Shuang Xia
Journal:  Pathol Res Pract       Date:  2018-03-06       Impact factor: 3.250

Review 5.  Advances in diagnosis and treatment of metastatic cervical cancer.

Authors:  Haoran Li; Xiaohua Wu; Xi Cheng
Journal:  J Gynecol Oncol       Date:  2016-07       Impact factor: 4.401

Review 6.  Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer.

Authors:  Gary M Clifford; Stephen Tully; Silvia Franceschi
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

7.  MicroRNAs as markers of progression in cervical cancer: a systematic review.

Authors:  Barbara Pardini; Daniela De Maria; Antonio Francavilla; Cornelia Di Gaetano; Guglielmo Ronco; Alessio Naccarati
Journal:  BMC Cancer       Date:  2018-06-27       Impact factor: 4.430

Review 8.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

9.  Locally advanced cervical cancer: A study of 5-year outcomes.

Authors:  Supriya Chopra; Meetakshi Gupta; Ashwathy Mathew; Umesh Mahantshetty; Reena Engineer; G Lavanya; Sudeep Gupta; Jaya Ghosh; Meenakshi Thakur; Kedar Deodhar; Santosh Menon; Bharat Rekhi; Jyoti Bajpai; Seema Gulia; Amita Maheshwari; Rajendra Kerkar; T S Shylasree; S K Shrivastava
Journal:  Indian J Cancer       Date:  2018 Jan-Mar       Impact factor: 1.224

Review 10.  Cervical Cancer Prevalence, Incidence and Mortality in Lowzzm321990and Middle Income Countries: A Systematic Review

Authors:  Aamod Dhoj Shrestha; Dinesh Neupane; Peter Vedsted; Per Kallestrup
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
View more
  2 in total

Review 1.  The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.

Authors:  Emad A Ahmed; Peramaiyan Rajendran; Harry Scherthan
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 2.  The Underappreciated Role of Epithelial Mesenchymal Transition in Chronic Obstructive Pulmonary Disease and Its Strong Link to Lung Cancer.

Authors:  Malik Quasir Mahmood; Shakti D Shukla; Chris Ward; Eugene Haydn Walters
Journal:  Biomolecules       Date:  2021-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.